InsidersTradesSigma
Explore the full directors' dealings record of AMAG PHARMACEUTICALS INC., a listed equity based in United States. Shares trade on US US, under the authority of SEC (Form 4). Market capitalisation: €1,899.2bn. The latest transaction was disclosed on 5 January 2016 (Attribution). Among the most active insiders: Grund Nicholas. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
1 of 1 declaration